Manufacturer record
Syncom Healthcare Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Syncom Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between January 2019 and July 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Syncom Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Albendazole tablets IP 400 mg (ZEEBEE - Tablet) | JDT0047Mfg 2018-08 · Exp 2021-07 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2021 |
| Diclofenac gel B.P. 1% w/w | 8916Mfg 2019-09 · Exp 2020-08 | ASSAYAssay | RDTL GuwahatiState lab | Aug 2020 |
| Levocetirizine Hydrochloride Tablets I.P. 5 mg | SHT8188Mfg 2018-04 · Exp 2021-03 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2020 |
| Cetirizine Hydrochloride Tablets IP 10mg | SHT9114Mfg 2019-01 · Exp 2021-12 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Sep 2019 |
| LEVOCETIRIZINE HYDROCHLORIDE TABLETS IP 5 MG | SHT8957Mfg 2018-09 · Exp 2021-08 | Test of DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2019 |
| LEVOCETIRIZINE HYDROCHLORIDE TABLETS IP 5 MG | SHT7550Mfg 2017-12 · Exp 2020-11 | Dissolution (Levocetirizine Hydrochloride)Dissolution | RDTL ChandigarhCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.